Live Analyst Rating Changes 8326 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David S Macdonald
TRU
David S Macdonald
Wall Street Analyst
★★★★☆
#633
on 13Foresight · ranked by our own returns
59%
Success Rate
+2.5%
Average Return
27 of 46 calls profitable · -1.6% vs benchmark
📈 Across the calls we could measure, roughly 59% of David S Macdonald's ratings turned a profit when each position was held for 2 year — averaging +2.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

153 Buy 90 Hold 0 Sell
David's Stock Coverage 31 ratings · 2026-07-15
Company Date Position Consensus Price Target 2-Yr Return
CON
Concentra Group Holdings Parent, Inc.
Jul 14, 2026 BUY Strong Buy
+5.8% avg upside
10 analysts
$37.00
20.19% Upside
+0.2%
CNC
Centene
Jul 14, 2026 BUY Buy
+0.2% avg upside
29 analysts
$78.00
13.89% Upside
-3.1%
CYH
Community Health
Jul 14, 2026 HOLD Sell
+34.9% avg upside
18 analysts
·
CVS
CVS Health
Jul 14, 2026 BUY Strong Buy
-2.3% avg upside
39 analysts
$118.00
11.54% Upside
+0.0%
DVA
DaVita
Jul 14, 2026 HOLD Hold
-27.7% avg upside
17 analysts
$250.00
7.47% Upside
·
HCA
HCA Healthcare
Jul 14, 2026 BUY Strong Buy
+14.1% avg upside
35 analysts
+3.6%
HUM
Humana
Jul 14, 2026 HOLD Buy
-13.4% avg upside
34 analysts
$415.00
2.16% Upside
·
MD
Pediatrix Medical Group
Jul 14, 2026 HOLD Buy
-12.8% avg upside
14 analysts
$28.00
13.99% Upside
·
MOH
Molina Healthcare
Jul 14, 2026 HOLD Buy
-1.8% avg upside
26 analysts
$250.00
4.17% Upside
+0.0%
THC
Tenet Healthcare
Jul 14, 2026 BUY Strong Buy
+15.0% avg upside
26 analysts
+0.0%
ENSG
The Ensign Group
Jul 14, 2026 HOLD Strong Buy
-3.8% avg upside
9 analysts
$202.00
21.20% Upside
+0.0%
UNH
UnitedHealth
Jul 14, 2026 BUY Strong Buy
-0.1% avg upside
36 analysts
$480.00
12.95% Upside
-1.2%
ELV
Elevance Health
Jul 14, 2026 BUY Strong Buy
+4.5% avg upside
32 analysts
$475.00
11.84% Upside
-8.5%
PNTG
Pennant Group
Jul 14, 2026 BUY Strong Buy
-7.5% avg upside
9 analysts
$48.00
21.49% Upside
·
AVAH
Aveanna Healthcare Holdings
Jul 14, 2026 HOLD Buy
-1.3% avg upside
17 analysts
$11.00
17.43% Upside
+0.0%
ARDT
Ardent Health Partners, Inc.
Jul 14, 2026 BUY Buy
+42.8% avg upside
16 analysts
$12.00
27.43% Upside
·
PACS
PACS Group Inc
Jun 30, 2026 BUY Strong Buy
+1.7% avg upside
9 analysts
+3.2%
EHC
Encompass Health
Jun 26, 2026 BUY Strong Buy
+2.8% avg upside
22 analysts
$140.00
30.03% Upside
+8.9%
AHCO
AdaptHealth
Jun 24, 2026 BUY Strong Buy
+37.8% avg upside
12 analysts
$14.00
38.03% Upside
+1.6%
GRDN
Guardian Pharmacy Services, Inc. Class A
Jun 22, 2026 BUY Strong Buy
+4.0% avg upside
7 analysts
$47.00
18.60% Upside
-2.9%
FMS
Fresenius Medical Care
May 21, 2026 HOLD Hold
+76.3% avg upside
14 analysts
$26.00
7.44% Upside
+11.6%
RDNT
Radnet
May 19, 2026 BUY Strong Buy
+27.2% avg upside
10 analysts
$90.00
43.33% Upside
+23.0%
CI
Cigna
May 05, 2026 BUY Strong Buy
+14.9% avg upside
29 analysts
$350.00
16.21% Upside
+7.1%
LH
Labcorp Holdings
May 04, 2026 BUY Strong Buy
-5.3% avg upside
36 analysts
$320.00
15.81% Upside
+10.5%
OPCH
Option Care Health
May 01, 2026 BUY Strong Buy
+38.3% avg upside
20 analysts
$30.00
40.56% Upside
+7.7%
DGX
Quest Diagnostics
Apr 22, 2026 HOLD Buy
-16.8% avg upside
33 analysts
+2.1%
SAIC
Science Applications
Apr 03, 2023 HOLD Buy
-9.6% avg upside
20 analysts
$120.00
5.06% Upside
+6.0%
PRVA
Privia Health Group
Aug 12, 2022 BUY Strong Buy
+13.3% avg upside
26 analysts
$48.00
70.78% Upside
-47.3%
AGL
Agilon Health
Jul 14, 2022 BUY Buy
-58.6% avg upside
26 analysts
$33.00
73.30% Downside
-75.8%
HCSG
Healthcare Services
Oct 13, 2020 HOLD Buy
+2.1% avg upside
12 analysts
-41.3%
DE:FME
Fresenius Medical Care AG & Co. KGaA
May 02, 2019 BUY Buy
+20.1% avg upside
22 analysts
$43.87
3.38% Upside
·
🔒 26 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
David S Macdonald — Frequently Asked Questions
How accurate are David S Macdonald's stock ratings?
Based on the calls 13Foresight could measure, about 59% of David's ratings were profitable over a one-year hold, with an average return of +5.6% per rating, or +2.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is David ranked on 13Foresight?
David S Macdonald is currently ranked #633 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on CON, CNC, CYH, CVS, DVA, HCA, HUM, MD, MOH, THC, ENSG, UNH and 19 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.